Tatsuro Watanabe
6PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jan 21, 2025
Treating Hematological Malignancies With OR-2100, an Orally Bioavailable Prodrug of Decitabine.Tatsuro Watanabe, Keisuke Kidoguchi, Shinya Kimura
|Jun 05, 2024
DNA demethylating agents for chemoprevention of oncovirus-associated leukemogenesis.Yuta Yamamoto, Tatsuro Watanabe, Hiroshi Ureshino
|Jan 08, 2024
Reprogramming of pyrimidine nucleotide metabolism supports vigorous cell proliferation of normal and malignant T cells.Tatsuro Watanabe, Yuta Yamamoto, Yuki Kurahashi
|Mar 02, 2023
Combination of a New Oral Demethylating Agent, OR2100, and Venetoclax for Treatment of Acute Myeloid Leukemia.Kazuharu Kamachi, Hiroshi Ureshino, Tatsuro Watanabe
|Dec 14, 2022
Dual targeting of aberrant DNA and histone methylation synergistically suppresses tumor cell growth in ATL.Yuki Kurahashi, Tatsuro Watanabe, Yuta Yamamoto
|Dec 16, 2021
Adult T-cell leukemia-lymphoma acquires resistance to DNA demethylating agents through dysregulation of enzymes involved in pyrimidine metabolism.Nao Yoshida-Sakai, Tatsuro Watanabe, Yuta Yamamoto
Pageof 1
Frequent Collaborators
3 joint publications
Hiroshi Ureshino
3 joint publications
Nao Yoshida-Sakai
3 joint publications
Shinya Kimura
2 joint publications
Toshikazu Ushijima
2 joint publications
Kazuharu Kamachi
2 joint publications
Kazunori Kawasoe
1 joint publications
Naoko Hattori
1 joint publications
Yuki Fukuda-Kurahashi
1 joint publications
Toshimi Hoshiko
1 joint publications
Yuta Yamamoto
